• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-98 的下调通过靶向 ALK1 促进低氧性肺动脉高压。

Downregulation of miR‑98 contributes to hypoxic pulmonary hypertension by targeting ALK1.

机构信息

Department of Respiratory Medicine, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China.

出版信息

Mol Med Rep. 2019 Sep;20(3):2167-2176. doi: 10.3892/mmr.2019.10482. Epub 2019 Jul 9.

DOI:10.3892/mmr.2019.10482
PMID:31322216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6691262/
Abstract

Chronic hypoxia is one of the most common causes of secondary pulmonary hypertension, the mechanisms of which remain unclear. MicroRNAs (miRNAs) are small, noncoding RNAs that inhibit the translation or accelerate the degradation of mRNA. Previous studies have demonstrated that deregulated miRNA expression contributes to various cellular processes including cell apoptosis and proliferation, which are mediated by hypoxia. In the present study, the expression of miR‑98 was identified to be decreased in the lung tissue of a hypoxic pulmonary hypertension (HPH) rat model and pulmonary artery (PA) smooth muscle cells (PASMCs), which was induced by hypoxia. By transfecting miR‑98 mimics into PASMCs, the high expression of miR‑98 inhibited cell proliferation, but upregulated hypoxia‑induced PASMCs apoptosis. However, these effects of miR‑98 mimics on PASMCs were reversed by ALK1 (activin receptor‑like kinase‑1) overexpression. ALK1 was identified as a candidate target of miR‑98. In addition, overexpressing miR‑98 markedly decreased the pulmonary artery wall thickness and the right ventricular systolic pressure in rats induced by hypoxia. These results provided clear evidence that miR‑98 was a direct regulator of ALK1, and that the downregulation of miR‑98 contributed to the pathogenesis of HPH. These results provide a novel potential therapeutic strategy for the treatment of HPH.

摘要

慢性缺氧是继发性肺动脉高压最常见的原因之一,其机制尚不清楚。微小 RNA(miRNA)是一种小的非编码 RNA,可抑制 mRNA 的翻译或加速其降解。先前的研究表明,miRNA 表达失调参与了各种细胞过程,包括细胞凋亡和增殖,这些过程是由缺氧介导的。在本研究中,鉴定出 miR-98 在缺氧性肺动脉高压(HPH)大鼠模型和肺动脉平滑肌细胞(PASMC)中的表达降低,这是由缺氧诱导的。通过将 miR-98 模拟物转染到 PASMC 中,高表达的 miR-98 抑制细胞增殖,但上调缺氧诱导的 PASMC 凋亡。然而,miR-98 模拟物对 PASMC 的这些作用被 ALK1(激活素受体样激酶-1)过表达逆转。ALK1 被鉴定为 miR-98 的候选靶标。此外,过表达 miR-98 可显著降低缺氧诱导的大鼠肺动脉壁厚度和右心室收缩压。这些结果提供了明确的证据表明 miR-98 是 ALK1 的直接调节因子,miR-98 的下调有助于 HPH 的发病机制。这些结果为 HPH 的治疗提供了一种新的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/fff8ab84e2a3/MMR-20-03-2167-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/c7e8e819bdaa/MMR-20-03-2167-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/bc96d3bde00a/MMR-20-03-2167-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/d640b9425e9a/MMR-20-03-2167-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/7e39ea7d87f2/MMR-20-03-2167-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/fff8ab84e2a3/MMR-20-03-2167-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/c7e8e819bdaa/MMR-20-03-2167-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/bc96d3bde00a/MMR-20-03-2167-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/d640b9425e9a/MMR-20-03-2167-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/7e39ea7d87f2/MMR-20-03-2167-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1f/6691262/fff8ab84e2a3/MMR-20-03-2167-g04.jpg

相似文献

1
Downregulation of miR‑98 contributes to hypoxic pulmonary hypertension by targeting ALK1.miR-98 的下调通过靶向 ALK1 促进低氧性肺动脉高压。
Mol Med Rep. 2019 Sep;20(3):2167-2176. doi: 10.3892/mmr.2019.10482. Epub 2019 Jul 9.
2
MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.微小RNA-103/107通过靶向低氧诱导因子-1β参与低氧诱导的肺动脉平滑肌细胞增殖。
Life Sci. 2016 Feb 15;147:117-24. doi: 10.1016/j.lfs.2016.01.043. Epub 2016 Jan 29.
3
TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension.TRB3 通过激活低氧性肺动脉高压中的 MAPK 信号通路来介导血管重构。
Respir Res. 2021 Dec 14;22(1):312. doi: 10.1186/s12931-021-01908-4.
4
Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension.微小RNA-214和PTEN的失调促成了缺氧性肺动脉高压的发病机制。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 19;12:1781-1791. doi: 10.2147/COPD.S104627. eCollection 2017.
5
MicroRNA let-7g inhibited hypoxia-induced proliferation of PASMCs via G/G cell cycle arrest by targeting c-myc.微小 RNA let-7g 通过靶向 c-myc 抑制 G/G 细胞周期阻滞,从而抑制低氧诱导的 PASMCs 增殖。
Life Sci. 2017 Feb 1;170:9-15. doi: 10.1016/j.lfs.2016.11.020. Epub 2016 Nov 24.
6
Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.CapG在肺动脉平滑肌细胞增殖、凋亡及缺氧诱导的肺动脉高压大鼠模型中的作用
Exp Lung Res. 2016 Apr;42(3):142-53. doi: 10.3109/01902148.2016.1160304.
7
MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2.miRNA let-7b 通过靶向 ACE2 促进低氧性肺动脉高压的发生。
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L547-L557. doi: 10.1152/ajplung.00387.2018. Epub 2019 Jan 10.
8
The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C.microRNA-328 通过靶向胰岛素样生长因子 1 受体和 L 型钙通道-α1C 调节低氧性肺动脉高压。
Hypertension. 2012 May;59(5):1006-13. doi: 10.1161/HYPERTENSIONAHA.111.185413. Epub 2012 Mar 5.
9
Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension.长链非编码 RNA-母系表达基因 3 促进低氧性肺动脉高压。
Mol Ther. 2019 Dec 4;27(12):2166-2181. doi: 10.1016/j.ymthe.2019.07.022. Epub 2019 Aug 22.
10
Hypoxia is involved in hypoxic pulmonary hypertension through inhibiting the activation of FGF2 by miR-203.缺氧通过 miR-203 抑制 FGF2 的激活而参与低氧性肺动脉高压的形成。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8866-8876. doi: 10.26355/eurrev_201812_16655.

引用本文的文献

1
Exploring the pathogenesis of pulmonary vascular disease.探索肺血管疾病的发病机制。
Front Med (Lausanne). 2024 Jul 10;11:1402639. doi: 10.3389/fmed.2024.1402639. eCollection 2024.
2
MicroRNA-98: the multifaceted regulator in human cancer progression and therapy.微小RNA-98:人类癌症进展与治疗中的多面调节因子
Cancer Cell Int. 2024 Jun 13;24(1):209. doi: 10.1186/s12935-024-03386-2.
3
Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.解析肺动脉高压的表观遗传学景观:对个体化医学发展的启示。

本文引用的文献

1
Genetic variants in a Polish population of patients with pulmonary arterial hypertension: sequencing of BMPR2, ALK1, and ENG genes.波兰肺动脉高压患者群体中的遗传变异:BMPR2、ALK1 和 ENG 基因测序。
Kardiol Pol. 2018;76(5):852-859. doi: 10.5603/KP.a2018.0034. Epub 2018 Jan 19.
2
Hypoxia-induced microRNA-26b inhibition contributes to hypoxic pulmonary hypertension via CTGF.低氧诱导的 microRNA-26b 抑制通过 CTGF 导致低氧性肺动脉高压。
J Cell Biochem. 2018 Feb;119(2):1942-1952. doi: 10.1002/jcb.26355. Epub 2017 Sep 18.
3
Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
J Transl Med. 2023 Jul 17;21(1):477. doi: 10.1186/s12967-023-04339-5.
4
miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.miR-155-5p 通过靶向 PYGL 调节低氧诱导的肺动脉平滑肌细胞功能。
Bioengineered. 2022 May;13(5):12985-12997. doi: 10.1080/21655979.2022.2079304.
5
Non-Coding RNA Networks in Pulmonary Hypertension.肺动脉高压中的非编码RNA网络
Front Genet. 2021 Nov 30;12:703860. doi: 10.3389/fgene.2021.703860. eCollection 2021.
6
Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes.肺动脉高压中的性别二态性:性染色体的作用。
Antioxidants (Basel). 2021 May 14;10(5):779. doi: 10.3390/antiox10050779.
7
Genetic Delivery and Gene Therapy in Pulmonary Hypertension.遗传性肺动脉高压的基因传递和基因治疗。
Int J Mol Sci. 2021 Jan 25;22(3):1179. doi: 10.3390/ijms22031179.
8
LncRNA ENST00000563492 promoting the osteogenesis-angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by functions as a ceRNA for miR-205-5p.LncRNA ENST00000563492 通过作为 miR-205-5p 的 ceRNA 促进骨间充质干细胞 (BMSCs) 中的成骨-血管生成偶联过程。
Cell Death Dis. 2020 Jun 25;11(6):486. doi: 10.1038/s41419-020-2689-4.
转化生长因子-β通过激活素受体样激酶1刺激新生小鼠肺动脉平滑肌细胞和成纤维细胞中的Smad1/5信号通路。
Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L615-L627. doi: 10.1152/ajplung.00079.2017. Epub 2017 Jun 22.
4
Genetic Insights into Pulmonary Arterial Hypertension. Application of Whole-Exome Sequencing to the Study of Pathogenic Mechanisms.肺动脉高压的遗传学见解。全外显子组测序在致病机制研究中的应用。
Am J Respir Crit Care Med. 2016 Aug 15;194(4):393-7. doi: 10.1164/rccm.201603-0577ED.
5
Elevated levels of plasma transforming growth factor-β1 in idiopathic and heritable pulmonary arterial hypertension.特发性和遗传性肺动脉高压患者血浆转化生长因子-β1水平升高。
Int J Cardiol. 2016 Nov 1;222:368-374. doi: 10.1016/j.ijcard.2016.07.192. Epub 2016 Jul 29.
6
Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.CapG在肺动脉平滑肌细胞增殖、凋亡及缺氧诱导的肺动脉高压大鼠模型中的作用
Exp Lung Res. 2016 Apr;42(3):142-53. doi: 10.3109/01902148.2016.1160304.
7
Long noncoding RNA expression profiles of hypoxic pulmonary hypertension rat model.低氧性肺动脉高压大鼠模型的长链非编码RNA表达谱
Gene. 2016 Mar 15;579(1):23-8. doi: 10.1016/j.gene.2015.12.044. Epub 2015 Dec 23.
8
[Updated clinical classification of pulmonary hypertension].[肺动脉高压的更新临床分类]
Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:45-54.
9
BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway.骨形态发生蛋白-9通过ALK1介导的途径调节血管平滑肌细胞的成骨细胞分化和钙化。
J Cell Mol Med. 2015 Jan;19(1):165-74. doi: 10.1111/jcmm.12373. Epub 2014 Oct 9.
10
Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).肺动脉高压中的血管重构过程,重点关注 miR-204 和 miR-126(2013 年 Grover 会议系列)。
Pulm Circ. 2014 Jun;4(2):175-84. doi: 10.1086/675980.